oldid143831

Actavis focuses on exports rather than high profit margins

Icelandic giant Actavis, which purchased the Romanian pharmaceuticals manufacturer Sindan Bucuresti for 147.5 million euros last year, is registering a profit margin on the Romanian market comparable to the other markets on which it operates, with domestic sal...